People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Xynomic Pharmaceuticals Holdings, Inc. | — | Pharmaceuticals | Series A | $15.0M | $464.6M | 2019 |
Yinglin Mark Xu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yinglin Mark Xu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wentao Jason Wu | 1 | 1 |
| Tingzhi Jason Qian | 1 | 1 |
| Jiayuan James Tong | 1 | 1 |
| Charles Vincent Prizzi | 1 | 1 |
| Thomas Coco Folinsbee | 1 | 1 |
| Peidong Richard Wu | 1 | 1 |
| Adam Richard Inglis | 1 | 1 |
| Jinwei Coco Kou | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.